Preoperative serum levels of cancer antigen 125 and carcinoembryonic antigen ratio can improve differentiation between mucinous ovarian carcinoma and other epithelial ovarian carcinomas
| Autor: | Geum Seon Sohn, Hanbyoul Cho, Doo Byung Chay, Ji Hui Choi, Jae Hoon Kim |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
medicine.medical_specialty
endocrine system diseases Serous carcinoma Gastroenterology lcsh:Gynecology and obstetrics CA125/CEA ratio 03 medical and health sciences 0302 clinical medicine Carcinoembryonic antigen Mucinous ovarian carcinoma Internal medicine Ovarian carcinoma medicine Carcinoma Mucinous carcinoma Stage (cooking) lcsh:RG1-991 030219 obstetrics & reproductive medicine biology Epithelial ovarian carcinoma business.industry Obstetrics and Gynecology Gynecologic Oncology medicine.disease female genital diseases and pregnancy complications Serous fluid 030220 oncology & carcinogenesis biology.protein Original Article business Clear cell |
| Zdroj: | Obstetrics & Gynecology Science Obstetrics & Gynecology Science, Vol 61, Iss 3, Pp 344-351 (2018) |
| ISSN: | 2287-8572 |
| Popis: | Objective The main aim of this study was to evaluate cancer antigen 125 (CA125)/carcinoembryonic antigen (CEA) ratio (CCR), as a reliable marker to differentiate ovarian mucinous carcinoma from other epithelial ovarian carcinomas (EOCs), namely serous, clear cell, and endometrioid carcinomas. Methods Female patients suffering from different kinds of EOCs whom were subjected to elective surgery at the Gangnam Severance Hospital between January 2008 and December 2016, were included in this study. The serum levels of CA125 and CEA were assayed using commercially available kits per the manufacturer''s instructions. Results The CCR in mucinous carcinoma (mean 32.1) was significantly lower than that of clear cell (mean 235.0) and endometrioid carcinoma (mean 427.0) in stage I (all P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|